You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

CHLOROQUINE PHOSPHATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Chloroquine Phosphate patents expire, and what generic alternatives are available?

Chloroquine Phosphate is a drug marketed by Hikma Pharms, Impax Labs, Ipca Labs Ltd, Md Pharm, Natco Pharma Ltd, Purepac Pharm, Suven Pharms, Teva, and Watson Labs. and is included in thirteen NDAs.

The generic ingredient in CHLOROQUINE PHOSPHATE is chloroquine phosphate. There are twenty drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the chloroquine phosphate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Chloroquine Phosphate

A generic version of CHLOROQUINE PHOSPHATE was approved as chloroquine phosphate by IMPAX LABS on August 29th, 2003.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CHLOROQUINE PHOSPHATE?
  • What are the global sales for CHLOROQUINE PHOSPHATE?
  • What is Average Wholesale Price for CHLOROQUINE PHOSPHATE?
Drug patent expirations by year for CHLOROQUINE PHOSPHATE
Recent Clinical Trials for CHLOROQUINE PHOSPHATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Agenus Inc.Phase 1
University of ArizonaPhase 1
Translational Genomics Research InstitutePhase 1

See all CHLOROQUINE PHOSPHATE clinical trials

Pharmacology for CHLOROQUINE PHOSPHATE
Drug ClassAntimalarial
Anatomical Therapeutic Chemical (ATC) Classes for CHLOROQUINE PHOSPHATE

US Patents and Regulatory Information for CHLOROQUINE PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 083082-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Md Pharm CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 087228-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 040516-001 Aug 29, 2003 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva CHLOROQUINE PHOSPHATE chloroquine phosphate TABLET;ORAL 087504-001 Jan 13, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.